Scientists Find Human Antibodies that Can Block Multiple Coronaviruses Including SARS-CoV-2

Media Type
Article
Publish or Event Date
Research Institution
Scripps Research
Short Title
Scientists Find Human Antibodies that Can Block Multiple Coronaviruses Including SARS-CoV-2
Content Coordinator
Content Manager

“COVID Rebound” Is Common, even in Untreated Patients

Kidney Lesions Associated with Risk of Heart Disease in Chronic Kidney Disease Patients

Media Type
Article
Publish or Event Date
Research Institution
Brigham and Women’s Hospital
Short Title
Kidney Lesions Associated with Risk of Heart Disease in Chronic Kidney Disease Patients
Content Coordinator
Content Manager

Bird Flu Associated with Hundreds of Seal Deaths in New England in 2022, Tufts Researchers Find

Media Type
Article
Publish or Event Date
Research Institution
Tufts University Cummings School of Veterinary Medicine
Short Title
Bird Flu Associated with Hundreds of Seal Deaths in New England in 2022, Tufts Researchers Find
Content Coordinator
Content Manager

$3M NIH Grant Supports Genomic Approach to Curing "Neglected" Disease

Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers

Media Type
Article
Publish or Event Date
Research Institution
Innovation Pharmaceuticals
Short Title
Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers
Content Coordinator
Content Manager

Engineering a Malaria Vaccine

Study Seeks to Identify Prenatal Allergy Risk Markers

Why Subvariants of the SARS-CoV-2 Virus Accelerated the Pandemic

Media Type
Article
Publish or Event Date
Research Institution
University of California San Diego School of Medicine
Short Title
Why Subvariants of the SARS-CoV-2 Virus Accelerated the Pandemic
Content Coordinator
Content Manager

Tulane University Awarded up to $16 Million to Bring Pneumonia Nasal Vaccine to Clinical Trials

Media Type
Article
Publish or Event Date
Research Institution
Tulane University
Short Title
Tulane University Awarded up to $16 Million to Bring Pneumonia Nasal Vaccine to Clinical Trials
Content Coordinator
Content Manager